1. Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells.
- Author
-
Chaves NL, Estrela-Lopis I, Böttner J, Lopes CA, Guido BC, de Sousa AR, and Báo SN
- Subjects
- Breast Neoplasms pathology, Cell Line, Tumor, Citric Acid chemistry, Endocytosis drug effects, Female, Humans, Microscopy, Electron, Transmission, Rhodium chemistry, Spectrum Analysis, Raman, Breast Neoplasms drug therapy, Citrates pharmacokinetics, Ferric Compounds pharmacokinetics, Nanoparticles chemistry, Rhodium pharmacokinetics
- Abstract
Nanocarriers have the potential to improve the therapeutic index of currently available drugs by improving their efficacy and achieving therapeutic steady-state levels over an extended period. The association of maghemite-rhodium citrate (MRC) nanoparticles (NPs) has the potential to increase specificity of the cytotoxic action. However, the interaction of these NPs with cells, their uptake mechanism, and subcellular localization need to be elucidated. This work evaluates the uptake mechanism of MRC NPs in metastatic and nonmetastatic breast cancer-cell models, comparing them to a nontumor cell line. MRC NPs uptake in breast cancer cells was more effective than in normal cells, with regard to both the amount of internalized material and the achievement of more strategic intracellular distribution. Moreover, this process occurred through a clathrin-dependent endocytosis pathway with different basal expression levels of this protein in the cell lines tested., Competing Interests: Disclosure The authors report no conflicts of interest in this work.
- Published
- 2017
- Full Text
- View/download PDF